DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis

被引:426
作者
Bernstein, C [1 ]
Bernstein, H
Payne, CM
Garewal, H
机构
[1] Univ Arizona, Coll Med, Dept Microbiol & Immunol, Tucson, AZ 85724 USA
[2] Tucson Vet Affairs Hosp, Tucson, AZ 85723 USA
关键词
DNA repair; apoptosis; carcinogenesis;
D O I
10.1016/S1383-5742(02)00009-1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Two systems are essential in humans for genome integrity, DNA repair and apoptosis. Cells that are defective in DNA repair tend to accumulate excess DNA damage, Cells defective in apoptosis tend to survive with excess DNA damage and thus allow DNA replication past DNA damages, causing mutations leading to carcinogenesis. It has recently become apparent that key proteins which contribute to cellular survival by acting in DNA repair become executioners in the face of excess DNA damage. Five major DNA repair pathways are homologous recombinational repair (HRR), non-homologous end joining (NHEJ), nucleotide excision repair (NER), base excision repair (BER) and mismatch repair (MMR), In each of these DNA repair pathways, key proteins occur with dual functions in DNA damage sensing/repair and apoptosis. Proteins with these dual roles occur in: (1) HPR (BRCA1, ATM, ATR, WRN, BLM, Tip60 and p53); (2) NHEJ (the catalytic subunit of DNA-PK); (3) NER (XPB, XPD, p53 and p33(ING1b)); (4) BER (Ref-1/Ape, poly (ADP-ribose) polymerase-1 (PARP-1) and p53); (5) MMR (MSH2, MSH6, MLH1 and PMS2). For a number of these dual-role proteins, germ line Mutations causing them to be defective also predispose individuals to cancer. Such proteins include BRCA1 ATM. WRN, BLM, p53. XPB, XPD, MSH2, MSH6. MLH1 and PMS2. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:145 / 178
页数:34
相关论文
共 293 条
  • [1] Achanta G, 2001, CANCER RES, V61, P8723
  • [2] c-Myc is necessary for DNA damage-induced apoptosis in the G2 phase of the cell cycle
    Adachi, S
    Obaya, AJ
    Han, ZY
    Ramos-Desimone, N
    Wyche, JH
    Sedivy, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (15) : 4929 - 4937
  • [3] The mitochondrial apoptosome: a killer unleashed by the cytochrome seas
    Adrain, C
    Martin, SJ
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (06) : 390 - 397
  • [4] Agami R, 1999, NATURE, V399, P809
  • [5] Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase
    Agarwal, ML
    Agarwal, A
    Taylor, WR
    Wang, ZQ
    Wagner, EF
    Stark, GR
    [J]. ONCOGENE, 1997, 15 (09) : 1035 - 1041
  • [6] Alberg Anthony J., 1997, Current Opinion in Oncology, V9, P505, DOI 10.1097/00001622-199711000-00003
  • [7] ENDOGENOUS MUTAGENS AND THE CAUSES OF AGING AND CANCER
    AMES, BN
    GOLD, LS
    [J]. MUTATION RESEARCH, 1991, 250 (1-2): : 3 - 16
  • [8] Inhibition of Bax channel-forming activity by Bcl-2
    Antonsson, B
    Conti, F
    Ciavatta, A
    Montessuit, S
    Lewis, S
    Martinou, I
    Bernasconi, L
    Bernard, A
    Mermod, JJ
    Mazzei, G
    Maundrell, K
    Gambale, F
    Sadoul, R
    Martinou, JC
    [J]. SCIENCE, 1997, 277 (5324) : 370 - 372
  • [9] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [10] Tumor suppressor p53 is required to modulate BRCA1 expression
    Arizti, P
    Fang, L
    Park, I
    Yin, YX
    Solomon, E
    Ouchi, T
    Aaronson, SA
    Lee, SW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) : 7450 - 7459